,,ii  #aadth ,,congress  #b;d ,session  
,s4 #cbji  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,july #ac1     
#bjaf ,ms4 ,klobuchar 7for herself1 ,mr4
 ,manchin1 and ,mr4 ,king7 introduced   
the following bill2 which was read twice
 and referred to the ,committee on      
,health1 ,education1 ,labor1 and        
,pensions  ,a ,,bill  ,to require the   
use of prescription drug monitoring     
programs and to facilitate information  
sharing among ,states4  #a4 ,short title
  ,this ,act may be cited as the        
,prescription ,drug ,monitoring ,act of 
#bjaf4  #b4 ,definitions ,in this ,act3 
7#a7 ,controlled substance ,the term    
controlled substance has the meaning    
given the term in section #ajb of the   
,controlled ,substances ,act 7#ba       
,u4,s4,c4 #hjb74  7#b7 ,covered ,state  
,the term covered ,state means a ,state 
that receives funding under the ,harold 
,rogers ,prescription ,drug ,monitoring 
,program established under the          
,departments of ,commerce1 ,justice1 and

 ,state1 the ,judiciary1 and ,related   
,agencies ,appropriations ,act1 #bjjb   
7,public ,law #ajg-gg2 #aae ,stat4 #gdh7
 or the controlled substance monitoring 
program under section #cii,o of the     
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bhj;g-#c74  7#c7 ,dispenser  
,the term dispenser-- 7,a7 means person 
licensed or otherwise authorized by a   
,state to deliver a prescription drug   
product to a patient or an agent of the 
patient2 and  7,b7 does not include a   
person involved in oversight or payment 
for prescription drugs4  7#d7 ,,pdmp    
,the term ,,pdmp means a prescription   
drug monitoring program4  7#e7          
,practitioner ,the term practitioner    
means a practitioner registered under   
section #cjc7;f7 of the ,controlled     
,substances ,act 7#ba ,u4,s4,c4         
#hbc7;f77 to prescribe1 administer1 or  
dispense controlled substances4  7#f7   
,state ,the term ,state means each of   
the several ,states and the ,district of
 ,columbia4  #c4 ,prescription drug     

monitoring program requirements  7a7 ,in
 general ,beginning #b years after the  
date of enactment of this ,act1 each    
covered ,state shall require--  7#a7    
each prescribing practitioner within the
 covered ,state or their designee1 who  
shall be licensed or registered         
healthcare professionals or other       
employees who report directly to the    
practitioner1 to consult the ,,pdmp of  
the covered ,state before initiating    
treatment with a prescription for a     
controlled substance listed in schedule 
,,ii1 ,,iii1 or ,,iv of section #bjb7;c7
 of the ,controlled ,substances ,act    
7#ba ,u4,s4,c4 #hab7;c771 and every #c  
months thereafter as long as the        
treatment continues2  7#b7 the ,,pdmp of
 the covered ,state to provide proactive
 notification to a practitioner when    
patterns indicative of controlled       
substance misuse1 including opioid      
misuse1 are detected2  7#c7 each        
dispenser within the covered ,state to  
report each prescription for a          

controlled substance dispensed by the   
dispenser to the ,,pdmp not later than  
#bd hours after the controlled substance
 is dispensed to the patient2 and  7#d7 
that the ,,pdmp make available a        
quarterly de-identified data set and an 
annual report for public and private    
use1 which shall1 at a minimum1 meet    
requirements established by the         
,attorney ,general1 in coordination with
 the ,secretary of ,health and ,human   
,services4  7b7 ,noncompliance ,if a    
covered ,state fails to comply with     
subsection 7a71 the ,attorney ,general  
or the ,secretary of ,health and ,human 
,services1 as appropriate1 may withhold 
grant funds from being awarded to the   
covered ,state under the ,harold ,rogers
 ,prescription ,drug ,monitoring        
,program established under the          
,departments of ,commerce1 ,justice1 and
 ,state1 the ,judiciary1 and ,related   
,agencies ,appropriations ,act1 #bjjb   
7,public ,law #ajg-gg2 #aae ,stat4 #gdh7
 or the controlled substance monitoring 

program under section #cii,o of the     
,public ,health ,service ,act 7#db      
,u4,s4,c4 #bhj;g-#c74  #d4 ,sharing     
,,pdmp information among ,states  7a7   
,requirement ,beginning #b years after  
the date of enactment of this ,act1 each
 covered ,state shall make the data     
contained in the ,,pdmp of the covered  
,state available to other ,states       
through the data-sharing single         
technology solution established under   
subsection 7b74  7b7 ,data-,sharing     
,single technology solution  7#a7 ,in   
general ,the ,attorney ,general1 in     
coordination with the ,secretary of     
,health and ,human ,services1 shall     
award1 on a competitive basis1 a grant  
to an eligible entity to establish and  
maintain an inter-,state data-sharing   
single hub to facilitate the sharing of 
,,pdmp data among ,states and the       
accessing of such data by practitioners4
  7#b7 ,requirements ,the data-sharing  
single hub established under paragraph  
7#a7-- 7,a7 shall--  7i7 allow ,states  

to retain ownership of the data         
submitted by the ,states2  7ii7 provide 
a source of de-identified data that can 
be used for statistical1 research1 or   
educational purposes2  7iii7 allow      
,state authorized users to access data  
from a ,,pdmp of a covered ,state       
without requiring a user fee2 and  7iv7 
conform with the standards of the       
,prescription ,monitoring ,information  
,exchange2 and  7,b7 may not--  7i7     
distribute1 in whole or in part1 any    
,,pdmp data without the express written 
consent of the ,,pdmp ,state authority2 
and  7ii7 limit1 in whole or in part1   
distribution of ,,pdmp data as approved 
by the ,,pdmp ,state authority4  7#c7   
,authorization of appropriations ,there 
are authorized to be appropriated to the
 ,attorney ,general #b1jjj1jjj for      
fiscal years #bjag through #bjbj to     
carry out this subsection4